John Cambier
From EverybodyWiki Bios & Wiki
John C. Cambier is an American immunologist and microbiologist, currently a Distinguished Professor at Anschutz Medical Campus, and also a published author.[1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30][31][32][33][34][35]
References
- ↑ "John Cambier". medschool.cuanschutz.edu. Retrieved July 23, 2021.
- ↑ "Cambier, John". worldcat.org. Retrieved December 11, 2016.
- ↑ "John C. Cambier, PhD". medschool.cuanschutz.edu.
- ↑ "DAA Awardee: John C. Cambier | University of Iowa Center for Advancement". www.foriowa.org.
- ↑ "Meet John Cambier". December 10, 2024.
- ↑ "John CAMBIER | Emeritus Distinguished Professor | Ph.D | University of Colorado, Denver | UCD | Research profile". ResearchGate.
- ↑ "Spotlight: Alumnus John Cambier, PhD | Carver College of Medicine - The University of Iowa". medicine.uiowa.edu.
- ↑ https://www.nationaljewish.org/njh/media/pdf/cv/pdf-cv-cambier_cv.pdf?ext=.pdf [bare URL PDF]
- ↑ "Distinguished Alumni Award Recipients | Medicine Alumni - Carver College of Medicine | The University of Iowa". alumni.medicine.uiowa.edu.
- ↑ https://www.nationaljewish.org/njh/media/pdf/cv/pdf-cv-cambier_cv.pdf [bare URL PDF]
- ↑ "John Cambier, PhD, MS | Profiles | School of Medicine | University of Colorado". som.cuanschutz.edu.
- ↑ Cambier, J. C.; Pleiman, C. M.; Clark, M. R. (March 6, 1994). "Signal transduction by the B cell antigen receptor and its coreceptors". Annual Review of Immunology. 12: 457–486. doi:10.1146/annurev.iy.12.040194.002325. PMID 8011288 – via PubMed.
- ↑ Gauld, Stephen B.; Cambier, John C. (October 18, 2004). "Src-family kinases in B-cell development and signaling". Oncogene. 23 (48): 8001–8006. doi:10.1038/sj.onc.1208075. PMID 15489917 – via PubMed.
- ↑ "Distinct Signal Thresholds for the Unique Antigen Receptor–Linked Gene Expression Programs in Mature and Immature B Cells | Journal of Experimental Medicine | Rockefeller University Press".
- ↑ "Continuous inhibitory signaling by both SHP-1 and SHIP-1 pathways is required to maintain unresponsiveness of anergic B cells | Journal of Experimental Medicine | Rockefeller University Press".
- ↑ Cambier, John C. (May 1, 2013). "Autoimmunity risk alleles: hotspots in B cell regulatory signaling pathways". The Journal of Clinical Investigation. 123 (5): 1928–1931. doi:10.1172/JCI69289 – via www.jci.org.
- ↑ Smith, Mia J.; Rihanek, Marynette; Coleman, Brianne M.; Gottlieb, Peter A.; Sarapura, Virginia D.; Cambier, John C. (May 6, 2018). "Activation of thyroid antigen-reactive B cells in recent onset autoimmune thyroid disease patients". Journal of Autoimmunity. 89: 82–89. doi:10.1016/j.jaut.2017.12.001. PMC 5902436. PMID 29233566 – via PubMed.
- ↑ Smith, Mia J.; Rihanek, Marynette; Coleman, Brianne M.; Gottlieb, Peter A.; Sarapura, Virginia D.; Cambier, John C. (May 6, 2018). "Activation of thyroid antigen-reactive B cells in recent onset autoimmune thyroid disease patients". Journal of Autoimmunity. 89: 82–89. doi:10.1016/j.jaut.2017.12.001. PMC 5902436. PMID 29233566 – via PubMed.
- ↑ https://pubs.acs.org/doi/abs/10.1021/acs.molpharmaceut.8b01250
- ↑ Franks, S. Elizabeth; Getahun, Andrew; Hogarth, P. Mark; Cambier, John C. (December 6, 2016). "Targeting B cells in treatment of autoimmunity". Current Opinion in Immunology. 43: 39–45. doi:10.1016/j.coi.2016.09.003. PMC 5127449. PMID 27718447 – via PubMed.
- ↑ Harley, Isaac T. W.; Allison, Kristen; Scofield, R. Hal (August 24, 2022). "Polygenic autoimmune disease risk alleles impacting B cell tolerance act in concert across shared molecular networks in mouse and in humans". Frontiers in Immunology. 13. doi:10.3389/fimmu.2022.953439 – via Frontiers.
- ↑ Wemlinger, Scott M.; Cambier, John C. (January 6, 2024). "Therapeutic tactics for targeting B lymphocytes in autoimmunity and cancer". European Journal of Immunology. 54 (1). doi:10.1002/eji.202249947 – via CrossRef.
- ↑ "AAI Announces Distinguished Fellows of AAI - Class of 2019!". www.aai.org.
- ↑ "The American Association of Immunologists - Distinguished Lecturers".
- ↑ "The American Association of Immunologists - 2024 Career Award Recipients".
- ↑ "Award Presentations & Lectures".
- ↑ "John Cambier | Immunology Summit-2015 | Conferenceseries Ltd". immunology.conferenceseries.com. September 28, 2015.
- ↑ "Cambier honored for leadership, vision". CU Connections. June 8, 2017.
- ↑ Cambier, J. C.; Ransom, J. T. (April 1, 1987). "Molecular Mechanisms of Transmembrane Signaling in B Lymphocytes". Annual Review of Immunology. 5 (Volume 5, 1987): 175–199. doi:10.1146/annurev.iy.05.040187.001135 – via www.annualreviews.org.
- ↑ Jin, Lei; Lenz, Laurel L.; Cambier, John C. (December 10, 2010). "Cellular reactive oxygen species inhibit MPYS induction of IFNβ". PloS One. 5 (12): e15142. doi:10.1371/journal.pone.0015142. PMC 3000824. PMID 21170271 – via PubMed.
- ↑ Jin, Lei; Getahun, Andrew; Knowles, Heather M.; Mogan, Jennifer; Akerlund, Linda J.; Packard, Thomas A.; Perraud, Anne-Laure; Cambier, John C. (March 15, 2013). "STING/MPYS mediates host defense against Listeria monocytogenes infection by regulating Ly6C(hi) monocyte migration". Journal of Immunology (Baltimore, Md.: 1950). 190 (6): 2835–2843. doi:10.4049/jimmunol.1201788. PMC 3593745. PMID 23378430 – via PubMed.
- ↑ Packard, Thomas A.; Cambier, John C. (October 1, 2013). "B lymphocyte antigen receptor signaling: initiation, amplification, and regulation". F1000prime Reports. 5: 40. doi:10.12703/P5-40. PMC 3790562. PMID 24167721 – via PubMed.
- ↑ "Immunological Reviews | Wiley". Wiley.com.
- ↑ https://lymphosign.com/about
- ↑ "John Cambier, Ph.D."
  | This article about a biologist from the United States is a stub. You can help EverybodyWiki by expanding it. |
This article "John Cambier" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:John Cambier. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
